The fifth session of the 14th meeting of the board of directors resolution notice

Source: 2020-1-20 10:24:01 tide of information network

Stock code: 002365 securities, yongan pharmaceutical bulletin number: 2020-02

Qianjiang Yongan Pharmaceutical Co., Ltd.

The fifth session of the 14th meeting of the board of directors resolution notice



The company and the board members to ensure that the information disclosure content true, accurate and complete, no false records, misleading statements or major omissions.

Qianjiang Yongan Pharmaceutical Co., Ltd. (hereinafter referred to as the "company") of the fifth session of the 14th meeting of the board of directors meeting notice on January 6, 2020, in writing, telephone, fax, E-mail and other forms to the company all the directors, the meeting held on January 10, 2020 in communication way, the meeting should participate in the review voting directors 6 people, the actual participation in 6 people review voting directors. The conference convened and held in accordance with the company law and the company's articles of association rules. Meeting in written way a secret ballot vote, passed the following resolution:

A, reviewed and adopted the "about 2016 restricted stock incentive plan third remove restricted period remove the achievements of restricted conditions bill

According to the company's 2016 restricted stock incentive plan (revised draft) ", the board of directors think the company in 2016 restricted stock incentive plan third remove restricted period remove restricted conditions have achievement, according to May 15, 2018, has completed 2017 rights and interests of the dispatch plan: in a total of 196455000 shares of base, as of December 31, 2017 to company's capital reserve fund for every 10 shares to the shareholders turn add 5 strands, the remove of the restricted restricted stock quantity will be adjusted accordingly. This conforms to the remove of the restricted conditions, therefore, incentive object for 143 people, can apply for cancel the restricted and listed the number of restricted stock circulation of 2.8365 million shares, accounting for 0.96% of the company at present the total equity.

Company independent director made independent advice to this bill. The bill details can be found in the published in the tide of information disclosure media designated by the CSRC net http://www.cninfo.com.cn "about 2016 restricted stock incentive plan third lift restricted period terminate the announcement of the achievements of restricted conditions and the independent director on matters related to the fifth session of the 14th meeting of the board of directors and independent opinions.

Company directors, Mr Wu Yuxi Ding Hongli lady are the restricted stock incentive plan incentive object, as a director associated to this bill to avoid a vote.

Vote: for 4 tickets, against zero votes, abstained 0 votes to avoid a vote two votes.

Second, reviewed and adopted the "about 2020 daily connection transaction is expected to bill

The board of directors of the company agreed to and huanggang yongan company